147 related articles for article (PubMed ID: 36882122)
61. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
Dönmez Y; Gündüz U
Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
[TBL] [Abstract][Full Text] [Related]
62. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
[TBL] [Abstract][Full Text] [Related]
63. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
[TBL] [Abstract][Full Text] [Related]
64. Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10.
Cheng L; Tachibana K; Zhang Y; Guo Jm; Kahori Tachibana K; Kameyama A; Wang H; Hiruma T; Iwasaki H; Togayachi A; Kudo T; Narimatsu H
FEBS Lett; 2002 Nov; 531(2):115-21. PubMed ID: 12417297
[TBL] [Abstract][Full Text] [Related]
65. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
[TBL] [Abstract][Full Text] [Related]
66. Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.
Freire-de-Lima L
Front Oncol; 2014; 4():59. PubMed ID: 24724053
[TBL] [Abstract][Full Text] [Related]
67. Biosynthesis of
Cejas RB; Lorenz V; Garay YC; Irazoqui FJ
J Biol Chem; 2019 Mar; 294(9):2997-3011. PubMed ID: 30591584
[TBL] [Abstract][Full Text] [Related]
68. cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3.
Bennett EP; Hassan H; Clausen H
J Biol Chem; 1996 Jul; 271(29):17006-12. PubMed ID: 8663203
[TBL] [Abstract][Full Text] [Related]
69. Advances in the relationship between glycosyltransferases and multidrug resistance in cancer.
Wu Y; Chen X; Wang S; Wang S
Clin Chim Acta; 2019 Aug; 495():417-421. PubMed ID: 31102590
[TBL] [Abstract][Full Text] [Related]
70. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
[TBL] [Abstract][Full Text] [Related]
71. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
Lee CH
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of analogues of GalNAc as substrates for enzymes of the mammalian GalNAc salvage pathway.
Pouilly S; Bourgeaux V; Piller F; Piller V
ACS Chem Biol; 2012 Apr; 7(4):753-60. PubMed ID: 22276930
[TBL] [Abstract][Full Text] [Related]
73. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
[TBL] [Abstract][Full Text] [Related]
74. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.
Zhang F; Zhang H; Wang Z; Yu M; Tian R; Ji W; Yang Y; Niu R
Biochem Pharmacol; 2014 Jan; 87(2):292-302. PubMed ID: 24239898
[TBL] [Abstract][Full Text] [Related]
75. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.
Gerken TA; Jamison O; Perrine CL; Collette JC; Moinova H; Ravi L; Markowitz SD; Shen W; Patel H; Tabak LA
J Biol Chem; 2011 Apr; 286(16):14493-507. PubMed ID: 21349845
[TBL] [Abstract][Full Text] [Related]
76. Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
Heffeter P; Jakupec MA; Körner W; Chiba P; Pirker C; Dornetshuber R; Elbling L; Sutterlüty H; Micksche M; Keppler BK; Berger W
Biochem Pharmacol; 2007 Jun; 73(12):1873-86. PubMed ID: 17445775
[TBL] [Abstract][Full Text] [Related]
77. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo.
Huang C; Huang S; Li H; Li X; Li B; Zhong L; Wang J; Zou M; He X; Zheng H; Si X; Liao W; Liao Y; Yang L; Bin J
J Exp Clin Cancer Res; 2018 Sep; 37(1):232. PubMed ID: 30231924
[TBL] [Abstract][Full Text] [Related]
78. Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer.
Ubillos L; Berriel E; Mazal D; Victoria S; Barrios E; Osinaga E; Berois N
Oncol Lett; 2018 Jul; 16(1):225-234. PubMed ID: 29928405
[TBL] [Abstract][Full Text] [Related]
79. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
[TBL] [Abstract][Full Text] [Related]
80. Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen.
Rivinoja A; Kokkonen N; Kellokumpu I; Kellokumpu S
J Cell Physiol; 2006 Jul; 208(1):167-74. PubMed ID: 16547942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
